Bioharvest Sciences Inc. income statement

In fiscal 2025, Bioharvest Sciences Inc. reported revenue of $34.5m, up 37.0% on the year before, operating income of −$5.6m (a -16.2% margin) and net income of −$11.1m. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Bioharvest Sciences Inc.: income statement, annual
Fiscal year	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	13	25	35
Cost of revenue	7	11	14
Gross profit	6	14	20
Operating income	−10	−7	−6
Income before tax	−13	−13	−11
Income tax	0	−0	−0
Net income	−13	−13	−11
EBITDA	−9	−6	−4

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: BHST vs VYGR BHST vs CCCC BHST vs FHTX

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Bioharvest Sciences Inc.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Bioharvest Sciences Inc.